Albanese, Alberto
 Distribuzione geografica
Continente #
EU - Europa 5.025
NA - Nord America 4.567
AS - Asia 1.835
AF - Africa 30
SA - Sud America 22
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.499
Nazione #
US - Stati Uniti d'America 4.544
DE - Germania 1.811
CN - Cina 857
SE - Svezia 794
UA - Ucraina 665
SG - Singapore 477
IT - Italia 377
IE - Irlanda 368
FR - Francia 332
ID - Indonesia 209
GB - Regno Unito 165
RU - Federazione Russa 152
FI - Finlandia 141
IN - India 124
TR - Turchia 83
AT - Austria 58
BE - Belgio 28
NL - Olanda 28
PL - Polonia 28
CI - Costa d'Avorio 25
HK - Hong Kong 25
JP - Giappone 24
BR - Brasile 17
CA - Canada 14
ES - Italia 11
IR - Iran 10
AU - Australia 9
BG - Bulgaria 8
RO - Romania 8
MX - Messico 7
CH - Svizzera 6
GR - Grecia 6
HU - Ungheria 6
CZ - Repubblica Ceca 5
EU - Europa 5
TW - Taiwan 5
DK - Danimarca 4
LT - Lituania 4
MD - Moldavia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
TH - Thailandia 3
VN - Vietnam 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
BZ - Belize 2
KR - Corea 2
KZ - Kazakistan 2
MT - Malta 2
PT - Portogallo 2
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 11.499
Città #
Chandler 857
Ashburn 546
Dublin 367
San Mateo 334
Singapore 334
Jacksonville 312
Jakarta 209
Nanjing 203
Wilmington 176
Lawrence 115
Dearborn 111
Boston 108
Ann Arbor 104
Moscow 100
Woodbridge 100
Nürnberg 85
Princeton 82
Redwood City 81
Milan 77
Izmir 73
Nanchang 67
Shenyang 66
New York 65
Houston 64
Beijing 62
Lancaster 61
Cattolica 57
Seattle 55
Fairfield 50
Norwalk 49
Mountain View 47
University Park 45
Bremen 41
Hangzhou 37
Jiaxing 37
Tianjin 37
Hebei 35
Detroit 34
Redmond 33
Changsha 32
Marseille 32
Boardman 31
Brussels 28
Kunming 28
Pune 27
Abidjan 25
Zhengzhou 23
Rome 21
Hong Kong 20
Falls Church 19
Kraków 19
Munich 19
Chicago 18
Simi Valley 18
Hefei 17
Los Angeles 17
Ningbo 15
Washington 15
Ypsilanti 15
Guangzhou 14
Leawood 14
Fremont 13
Busto Arsizio 11
Jinan 11
Shanghai 11
Frankfurt am Main 10
Fuzhou 9
London 9
Nuremberg 9
Trieste 9
Edinburgh 8
Lanzhou 8
Paris 8
Phoenix 8
Fort Worth 7
Taizhou 7
Budapest 6
Changchun 6
Costa Mesa 6
Groningen 6
Millbury 6
Toronto 6
Warsaw 6
Andover 5
Falkenstein 5
San Francisco 5
Tehran 5
Vienna 5
Cambridge 4
Chengdu 4
Chisinau 4
Formia 4
Guidonia Montecelio 4
Helsinki 4
Indiana 4
Newark 4
Amsterdam 3
Avellino 3
Banha 3
Bari 3
Totale 6.032
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 323
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 144
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 144
Mutation screening of the DYT6/THAP1 gene in Italy 139
Organization of central nervous system dopaminergic pathways 133
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 132
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 130
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 125
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease 121
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 120
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease 112
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 111
Clinical and genetic characteristics of late-onset Huntington's disease 110
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 105
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 103
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up 102
Analysis of blink rate in patients with blepharospasm 100
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 99
Early DEtection of wEaring off in Parkinson disease: the DEEP study 96
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 92
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 91
Advances in the genetics of primary torsion dystonia 91
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 89
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 89
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 87
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 87
Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation 87
Behavioral and personality features in patients with lateralized Parkinson's disease 85
Attentional networks in Parkinson's disease 85
Phenotypic characterisation of DYT13 primary torsion distonia. 84
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 84
Gastroenterologia. 83
Abnormal gating of somatosensory inputs in essential tremor. 82
Smooth muscle spasms and sphincters. 82
Botulinum toxin injected in the gastric wall reduces body weight and food intake rats. 82
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 81
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in a Italian family with cranial-cervical or upper limb onset. 79
PINK1 mutations are associated with sporadic early-onset parkinsonism. 78
Dystonia rating scales: critique and recommendations 77
Primary dystonias 76
Management of bladder, prostatic and pelvic floor disorders 75
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 75
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 75
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 74
Choice-option evaluation is preserved in early Huntington and Parkinson's disease 74
Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. 74
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 74
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 73
Onset and progression of primary torsion dystonia in sporadic and familial cases 73
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease 73
A 52-Year-Old Man with Myoclonic Jerks 73
EFNS guidelines on diagnosis and treatment of primary dystonias 71
Aging is associated with a diffuse impairment of forebrain cholinergic neurons 70
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome 70
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders 70
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 69
Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincter spasms. 69
Isolated limb dystonia as presenting feature of Parkin disease 69
Dystonic tremor 68
Phenomenology and classification of dystonia: a consensus update 68
Primary focal hyperhidrosis in a new family not linked to known loci 67
Dystonia: diagnosis and management 67
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 65
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 65
Correlation of cardiovascular autonomic function tests, magnetic resonance brain imaging and clinical features in suspect cases of multiple system atrophy 65
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. 64
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions 63
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 61
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 61
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. 60
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease 60
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement 60
Dystonia and tremor: the clinical syndromes with isolated tremor 60
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 60
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 59
Isolated cervical dystonia: diagnosis and classification 58
Effectiveness of higher doses of botulinum toxin to induce healing in patients eith chronic anal fissure. 58
Age-dependent loss of cholinergic neurones in basal ganglia of rats 58
Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers 58
Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia 58
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 58
Design and Operation of the Lombardy Parkinson's Disease Network 58
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease 57
Quantitative gait analysis in parkin disease: Possible role of dystonia 57
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. 56
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 56
Mood disorder following DBS of the left amygdaloid region in a dystonia patient with a dislodged electrode 56
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 56
The natural history of multiple system atrophy: a prospective European cohort study 56
Deep brain stimulation for Parkinson's disease: where do we stand? 55
Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts 55
Acetylcholinesterase and catecholamine distribution in the locus ceruleus of the rat 54
Reliability and validity of the range of motion scale (ROMS) in patients with abnormal postures 54
Therapeutic advances in dystonia 54
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin 53
"Gluing" phenotypes together: the case of GLUT1 53
Pallidal stimulation for acquired dystonia due to cerebral palsy: Beyond 5 years 53
Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity 52
Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-ervical or upper limb onset. 51
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 51
Totale 7.979
Categoria #
all - tutte 61.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020573 0 0 0 0 0 0 0 62 96 50 218 147
2020/20211.253 42 161 23 148 164 46 183 20 176 58 210 22
2021/20221.324 187 151 22 44 46 31 20 271 47 59 206 240
2022/20232.525 347 339 229 350 226 299 95 171 323 30 88 28
2023/20241.515 46 482 41 236 42 138 81 43 21 54 159 172
2024/2025818 64 90 258 55 174 82 76 19 0 0 0 0
Totale 11.661